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Background
The long-term outlook for regenerative medicine predicts
an increased need for high quality materials that are
compatible with the limited number of downstream pro-
cessing steps required for cell-based therapies. Large scale
manufacturing of adherent-dependent cell types necessi-
tates movement away from planar culture and toward
technologies such as stirred tank bioreactors where
suspension culture using microcarriers is enabled [1].
Microcarriers are available in a variety of base materials
including glass, polystyrene or dextran, and have been
coated or derivatized to carry charge, peptides or extra-
cellular matrix proteins such as collagen that may be ani-
mal-derived. Cell culture medium may also contain
animal-derived components. Fetal bovine serum (FBS) in
particular is associated with regulatory, supply, and con-
sistency challenges [2]. Eliminating this commonly-used
reagent will require thorough evaluation of animal origin-
free materials for compatibility with cell therapy applica-
tions. Here, we evaluated growth of human mesenchymal
stem/stromal cells (MSCs) with a variety of microcarriers
and cell culture media formulations. Not only was a wide
range of performance observed between the microcarriers
and media screened, but positive performance in static
culture was not necessarily predictive of that under agi-
tated conditions.
Materials and Methods
To evaluate different microcarriers, human adipose-
derived MSCs (aMSCs) were grown on a panel of
microcarriers in Petri dishes, 125 mL spinner flasks, or
Mobius® 3 L bioreactors in DMEM supplemented with
10% FBS and 8 ng/mL bFGF (DMEM FBS). TrypLE was
used to detach a MSCs from microcarriers to assess
recovery.
To evaluate different media formulations, human bone
marrow-derived MSCs (bmMSCs) were grown on gela-
tin-coated T-flasks for planar culture or seeded onto
collagen-coated microcarriers in 125 mL spinner flasks
for suspension culture. Planar cultures were maintained
in respective media from passage 4 to 8. Top perform-
ing media were further evaluated in microcarrier-based
suspension culture for 7 days. Serum (DMEMFBS) con-
trol flasks were run in parallel.
Cell were seeded at 3k cells / cm2 and 5.4 cm2 / mL of
culture surface was provided in all microcarrier experi-
ments. Nexcelom Cellometer® and NucleoCounter®
devices were used for cell counting.
Results
Six commercially-available microcarriers were tested for
their ability to support growth, detachment and viability
of a MSCs expanded in DMEM FBS. The evaluation was
conducted in both static culture (Petri dishes) and agi-
tated culture (spinner flasks). Microcarriers were
assigned a rank based on their overall performance in the
two platforms (Table 1). Microcarrier C was ranked the
best, primarily driven by high cell yields. Interestingly,
microcarriers B, D and E supported robust growth in sta-
tic culture with high day 7 fold increases, but did not per-
form as well under agitated conditions. Microcarriers A,
B and C were further evaluated in the Mobius® 3 L bior-
eactor where Microcarrier A supported best growth with
38 fold increase at day 11, representing over 5 population
doublings. This is consistent with microcarrier A yielding
best day 7 fold increase in the small scale culture screen.
However, the animal origin-free microcarriers B and C* Correspondence: aletta.schnitzler@emdmillipore.com
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were not able to support bmMSCs in the bioreactor,
yielding only 6 and 14 fold increases, respectively (data
not shown).
A number of serum-free (SF), xeno-free (XF) and low
serum (LS) media were evaluated for expansion of
bmMSCs in both planar and microcarrier-based suspen-
sion culture. Human platelet lysate (PL), a serum alterna-
tive, was also tested in the microcarrier-based culture.
Wide variation in the support of growth was observed
when bmMSCs were cultured for multiple passages in
planar culture in different media (Figure 1A). Only 4 of
the tested formulations, SF-1, SF-2, SF-3 and LS-1, had
cumulative populations doubling similar to the DMEM
FBS control. It should be noted that serum-free formula-
tions may still contain animal-derived materials. These
media, as well as XF-1 and aMEM PL were further
Table 1. Expansion of aMSCs with various microcarriers in static or agitated small scale platforms
Animal origin-free Day 7 fold increase % Recovery % Viability Overall cell yield (E+04 cells / mL) Rank
Petri Spinner Petri Spinner Petri Spinner Petri Spinner
Microcarrier Aa No 24 24 35 52 98 95 4.5 10.3 3
Microcarrier Ba Yes 28 15 46 58 92 91 9.2 8.3 2
Microcarrier Ca Yes 21 16 59 86 98 93 11.6 18.8 1
Microcarrier D Yes 28 12 25 84 97 95 2.9 13.5 4
Microcarrier E Yes 29 16 27 46 96 97 3.3 5.3 5
Microcarrier F No 24 17 22 30 91 90 1.9 2.4 6
aMicrocarriers chosen for further evaluation in a bioreactor process.
Figure 1 Media that supported hMSC growth in planar culture exhibited variable performance in microcarrier-based suspension
culture. hMSCs were expanded in various serum-free, xeno-free or serum-containing media in either planar culture (a) or microcarrier-based
culture (b, spinner flasks).
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evaluated in suspension culture (Figure 1B). Under agi-
tated conditions, 2 of the 3 SF formulations did not sup-
port bmMSC growth, even though they performed well
in planar culture. Robust growth was observed with
aMEM PL, whereas SF-3 and LS-1 were within range of
the serum control.
Conclusions
The observation that some microcarriers and cell culture
media that support robust MSC growth in static or pla-
nar culture do not perform in microcarrier-based suspen-
sion culture highlights the complex interaction between
culture surface, media formulation and hydrodynamic
forces introduced by agitation. Small scale platforms such
as Petri dishes and spinner flasks are convenient tools for
initial screening of many microcarriers or media, but a
sufficient number of top performers need to be moved
into bioreactor suspension culture for further evaluation.
A better understanding of the underlying biological
requirements of adherent-dependent cells in suspension
culture will foster the development of high quality
reagents that support expansion across platforms. The
combination of serum-free systems with animal origin-
free materials will be required to support the future
implementation of large scale manufacturing solutions
following clinical success of cell-based therapies.
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